Blueprint vs Eleos Health
Blueprint and Eleos Health occupy the same clinical space from opposite ends, and choosing between them is really choosing between commercial legibility and published clinical evidence. Blueprint is the bottom up product: self serve for individual therapists and small practices, more than 70,000 mental health professionals reported, usage priced with a free AI native EHR as the on ramp, graded A on commercial transparency and C on clinical evidence. Eleos is the top down enterprise platform: sold to behavioral health organisations, more than 200 reported, with the deepest published evidence in the category, including a randomised clinical trial in the Journal of Medical Internet Research and a real world accuracy study across more than 2.83 million micro dialogues, graded A on evidence and C on commercial transparency. If your failure mode is a contract you cannot price, start with Blueprint. If your failure mode is deploying clinical AI without peer reviewed proof, start with Eleos.
- Commercial legibility decides it: published per clinician pricing, a usage priced Assistant, and a free AI native EHR as the on ramp, the clearest cost picture in behavioral health documentation.
- You are a solo clinician or small practice: self serve deployment through a browser extension or EHR integration with no migration, and note types spanning individual, couples, family, and group therapy plus psychiatry workflows.
- Clinician level adoption at scale: more than 70,000 mental health professionals reported on the platform, with measurement based care tracking and intervention suggestions built in.
- Peer reviewed evidence is your bar: a randomised clinical trial in the Journal of Medical Internet Research, a machine learning study on therapy homework assignment, and a real world accuracy study across more than 2.83 million micro dialogues.
- You run a behavioral health organisation, not a practice: compliance scanning flags documentation errors before claim submission, treatment effectiveness analytics and leadership dashboards cover caseloads, and Eleos Outreach serves field based case managers.
- Language reach in community settings: recognition across more than 150 languages with notes rendered in clinically accurate English, deployed EHR agnostic through a lightweight browser embedding.
Side-by-Side
| Axis | B Blueprint |
E Eleos Health |
|---|---|---|
| AI Centrality | ||
| Autonomy and Oversight Model | ||
| Model and Technology Transparency | ||
| Clinical and Operational Evidence | ||
| AI Safety and PHI Stewardship | ||
| HIPAA and BAA Posture | ||
| Security Certifications and Trust Center | ||
| FDA and Regulatory Status | ||
| AI Governance and Bias Disclosure | ||
| EHR and Interoperability Depth | ||
| Deployment Model and Data Residency | ||
| Commercial Transparency | ||
| Setting and Specialty Coverage |
Adoption counts for both vendors are vendor published. Blueprint's clinical evidence grade is C because no peer reviewed outcome study was retrieved, and under this index's methodology scale of use does not substitute for evidence of benefit. Eleos's commercial transparency grade is C because pricing requires a sales conversation. Neither vendor published a security attestation at last verification, a gap this index has flagged across enterprise behavioral health, and neither publishes the data training and retention disclosure that Mentalyc states; buyers should confirm data terms on the tier they contract.